Published: 2016-08-01
Review
The Association between ANXA11 Gene Polymorphisms and Sarcoidosis: a Meta-Analysis and systematic review
Abstract 264 | PDF Downloads 73Page 102-111
An epidemiological perspective of the pathology and etiology of sarcoidosis
Abstract 1449 | PDF Downloads 254Page 112-116
Original Articles: Clinical Research
High-resolution CT predictors of hypersensitivity pneumonitis
Abstract 414 | PDF Downloads 432Page 117-123
Fatigue and health-related quality of life in patients with pulmonary sarcoidosis treated by oral Corticosteroids
Abstract 322 | PDF Downloads 467Page 124-129
Fatigue in sarcoidosis and idiopathic pulmonary fibrosis: differences in character and severity between diseases
Abstract 275 | PDF Downloads 298Page 130-138
Serum fibroblastic growth factor 23 in acute Sarcoidosis and normal kidney function
Abstract 190 | PDF Downloads 119Page 139-142
Platelet aggregability in patients with interstitial pneumonias
Abstract 196 | PDF Downloads 152Page 143-150
Evaluation of Tpeak-Tend interval and Tpeak-end/QT ratio in patients with Sarcoidosis
Abstract 297 | PDF Downloads 184Page 151-156
Exercise related ventilation dynamics and clinical correlates in patients with fibrotic idiopathic interstitial pneumonias
Abstract 284 | PDF Downloads 132Page 157-165
Case reports
Polishing surgical metal pieces, granulomatosis and mineralogical analysis
Abstract 213 | PDF Downloads 112Page 166-170
Pulmonary metastases from low grade sarcoma in a patient with pulmonary sarcoidosis. Sarcoidosis or sarcoid-like reaction?
Abstract 243 | PDF Downloads 159Page 171-174
Cardiac sarcoidosis – silent destroyer.
Abstract 213 | PDF Downloads 144Page 175-177
Sarcoidosis during etanercept treatment for rheumatoid arthritis in women with a history of bilateral oophorectomy
Abstract 603 | PDF Downloads 106Page 178-181
Extensive pulmonary sarcoid reaction in a patient with BMPR-2 associated idiopathic pulmonary arterial hypertension
Abstract 192 | PDF Downloads 54Page 182-185
Successful management of acute respiratory failure in an Idiopathic Pulmonary Fibrosis patient using an extracorporeal carbon dioxide removal system
Abstract 242 | PDF Downloads 112Page 186-190
Letter to editor
Repositioning ‘old’ drugs to treat rare diseases: arguing from the mechanism of action
Abstract 390 | PDF Downloads 114Page 191-194